BRIEF published on 03/18/2026 at 07:05, 1 month 25 days ago Performance de Mersen en 2025 et perspectives pour 2026 Investissements Résilience Financière Croissance 2026 Objectifs 2029 Performance 2025
BRIEF published on 03/18/2026 at 07:05, 1 month 25 days ago Groupe GORGE Achieves Strong Financial Performance in 2025 Revenue Growth Financial Performance Order Intake EBITDA Improvement Fundraising Efforts
BRIEF published on 03/18/2026 at 07:05, 1 month 25 days ago Le Groupe GORGE réalise de solides performances financières en 2025 Performance Financière Croissance Des Revenus Amélioration De L'EBITDA Prise De Commande Efforts De Collecte De Fonds
BRIEF published on 03/18/2026 at 07:05, 1 month 25 days ago Sanofi's Venglustat Earns Breakthrough Therapy Designation for Gaucher Disease Type 3 FDA Sanofi Breakthrough Therapy Venglustat Gaucher Disease
BRIEF published on 03/18/2026 at 07:05, 1 month 25 days ago Le venglustat de Sanofi obtient la désignation de thérapie innovante pour la maladie de Gaucher de type 3 FDA Sanofi Thérapie Révolutionnaire Venglustat Maladie De Gaucher
BRIEF published on 03/18/2026 at 07:05, 1 month 25 days ago Sanofi : Désignation de thérapie innovante pour le venglustat aux États-Unis FDA Sanofi Venglustat Maladie De Gaucher Découverte Médicale
BRIEF published on 03/18/2026 at 07:05, 1 month 25 days ago Sanofi: Breakthrough Therapy Designation for venglustat in the United States FDA Sanofi Venglustat Medical Discovery Gaucher's Disease
BRIEF published on 03/18/2026 at 07:00, 1 month 25 days ago Heidelberg Pharma to Receive Milestone Payment for HDP-101 Study in China Clinical Study Heidelberg Pharma HDP-101 Milestone Payment Huadong Medicine
BRIEF published on 03/18/2026 at 07:00, 1 month 25 days ago Heidelberg Pharma recevra un paiement d'étape pour l'étude HDP-101 en Chine Heidelberg Pharma HDP-101 Étude Clinique Paiement D'étape Médecine Huadong
BRIEF published on 03/18/2026 at 07:00, 1 month 25 days ago SMG Swiss Marketplace Group Reports Strong 2025 Financial Performance AI Innovation Revenue Growth Board Changes Dividends 2025 Financial Results
Published on 05/13/2026 at 00:00, 3 hours 47 minutes ago Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Published on 05/12/2026 at 23:35, 4 hours 12 minutes ago Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 5 hours 52 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 6 hours 5 minutes ago Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 23:47, 4 hours ago Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
Published on 05/12/2026 at 22:25, 5 hours 22 minutes ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 7 hours 26 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 8 hours 12 minutes ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 8 hours 12 minutes ago 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:15, 9 hours 32 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 9 hours 32 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 9 hours 37 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 9 hours 37 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 9 hours 57 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités
